EMILIN1
protein-codingelastin microfibril interfacer 1, the group of EMI domain containing|C1q domain containing
Gene summary
This gene encodes an extracellular matrix glycoprotein that is characterized by an N-terminal microfibril interface domain, a coiled-coiled alpha-helical domain, a collagenous domain and a C-terminal globular C1q domain. The encoded protein associates with elastic fibers at the interface between elastin and microfibrils and may play a role in the development of elastic tissues including large blood vessels, dermis, heart and lung. [provided by RefSeq, Sep 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0971179
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0859300
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0971179
Submitter: ClinGen
*EMILIN1* was first reported in relation to autosomal recessive Arterial Tortuosity-Bone Fragility Syndrome in 2022 (Adamo et al., PMID: 36351433). Affected individuals are reported with disease onset in the neonatal period or early childhood. Disease hallmarks include arterial tortuosity and bone fragility which can include multiple fractures. Some patients had additional features including dysmorphic facial features, cutis laxa, joint hypermobility, congenital heart malformations, arterial stenosis, and aortic root dilatation. Per criteria outlined by the ClinGen Lumping and Splitting guidelines, we found a difference in molecular mechanism, inheritance pattern and phenotype between patients with autosomal recessive Arterial Tortuosity-Bone Fragility Syndrome and those reported to have autosomal dominant neuronopathy, distal hereditary motor and/or autosomal dominant *EMILIN1*-related connective tissue disease. Therefore, autosomal recessive Arterial Tortuosity-Bone Fragility Syndrome (ClinGen term “EMILIN1-related arterial tortuosity syndrome”) will be curated separately from autosomal dominant forms of disease reported to be associated with this gene. Seven variants (two nonsense, five frameshift) have been reported in five probands in two publications (PMIDs: 36351433, 40062121) and are included in this curation. The mechanism of pathogenicity is reported to be loss of function. To date, all reported cases in the literature have been male and all variants are reported to result in loss of function of the MANE transcript. There is a second transcript which has not been well characterized and to date, all patients have either one or both loss-of-function variants located upstream of the start site for this transcript. This gene-disease relationship is also supported by experimental evidence including a mouse model, expression studies and functional data (PMIDs: 36351433, 14701737). These studies showed reduced EMILIN1 positive signals from elastic fibers in the skin and elastin core abnormalities. They also showed impaired EFEMP2 deposition and reduced LOX levels and enzyme activity. Knock-out mice recapitulated human phenotypes and had bone, collagen, and elastic fiber abnormalities (PMID:36351433). In summary, there is definitive evidence supporting the relationship between the *EMILIN1* gene and *EMILIN1*-related arterial tortuosity syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Heritable Thoracic Aortic Aneurysm and Dissection subgroup of the Hereditary Cardiovascular Disease GCEP on June 6, 2025 (SOP Version 11)
Inheritance Pattern: AD
Disease ID:MONDO:0859300
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Genitourinary; Musculoskeletal; Neurologic; Renal
Intervention: Cardiovascular
Rationale: The condition can involve congenital cardiovascular anomalies, and awareness may allow early diagnosis and management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EMILIN1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_007046.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 9 | 2 | 14 | ||
| missense | 1 | 202 | 15 | 4 | 222 | |
| nonsense | 1 | 1 | 1 | 3 | ||
| start loss | 0 | |||||
| frameshift | 3 | 1 | 4 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 5 | 2 | 207 | 24 | 6 | 244 |
Highest pathogenic variant AF is 0.00004106854
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_008977.1 | 8 | MANE Select | |
| Ensembl | ENSP00000369677.4 | 8 | MANE Select | |
| Ensembl | ENSP00000411201.1 | 5 | Standard | |
| Ensembl | ENSP00000535652.1 | 7 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| emilin1a | Danio rerio | Structure: thrombocyte Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- aortic valve morphogenesis
- cell adhesion
- cell-matrix adhesion
- positive regulation of gene expression
- negative regulation of gene expression
Molecular Function
- protein binding
- extracellular matrix constituent conferring elasticity
- identical protein binding
- integrin binding involved in cell-matrix adhesion
Cellular Component
- extracellular region
- collagen trimer
- extracellular space
- extracellular matrix
- integrin alpha4-beta1 complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000380320
- Coding exons
- 8
- Length
- 7837
- Individuals with no LoFs
- 125684
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 64
- Defined
- 125748
- p
- 0.000255
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.21 | 526 | 610 | 0.862 | 0.0000389 | 6307 |
| Missense (PolyPhen) | 185 | 235.83 | 0.78447 | 2513 | ||
| Synonymous | 1.12 | 243 | 266 | 0.913 | 0.0000154 | 2307 |
| Loss of Function | 3.82 | 11 | 35.6 | 0.309 | 0.00000190 | 374 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000063 | 0.000062 | rare |
| Latino/Admixed American | 0.00018 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000055 | 0.000054 | rare |
| Finnish | 0.0016 | 0.0016 | notable |
| European (Non-Finnish) | 0.00018 | 0.00017 | rare |
| South Asian | 0.000099 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be responsible for anchoring smooth muscle cells to elastic fibers, and may be involved not only in the formation of the elastic fiber, but also in the processes that regulate vessel assembly. Has cell adhesive capacity.;
Recessive Scores
- pRec
- 0.148
Intolerance Scores
- RVIS EVS
- -0.11
- RVIS percentile EVS
- 45.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.621
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |